OrthoPreserve
Restoring knee function with next-generation meniscus implant technology
Warsaw, United States · Founded 2023
- Headquarters
- Warsaw, Indiana
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- orthopreserve.com
- Last Round
- GrantSep 2023
- Rounds
- 1
About
OrthoPreserve is an Atlanta-based medical technology startup developing an artificial meniscus implant called Defender, designed to bridge the gap for patients with meniscus dysfunction who are not yet clinically ready for knee replacement. Founded by CEO Jonathan Schwartz (a Georgia Tech alumnus), COO Max Guillot, and surgeon advisor Dr. Cyrus Kump, the company originated from Schwartz's graduate thesis project. OrthoPreserve received FDA Breakthrough Device Designation in December 2024 and TAP enrollment in January 2025, and is a member company of Portal Innovations in Atlanta. The team of 3 co-founders is preparing for human clinical trials.
Summary
OrthoPreserve is a Medtech company based in Warsaw, United States, founded in 2023. Its most recent funding was a Grant round in Sep 2023.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...